Immunoregulatory properties of type-I interferons: relevance to multiple sclerosis and the hypereosinophilic syndrome.
Bartholomé
E J
EJ
Department of Neurology, Université Libre de Bruxelles, Brussels, Belgium.
Roufosse
F E
FE
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D006680:HLA Antigens / Q000187:drug effects; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000628:therapy*; D007370:Interferon Type I / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use*; D007378:Interleukins / Q000378:metabolism; D007694:Killer Cells, Natural / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D009103:Multiple Sclerosis / Q000628:therapy*; D006377:T-Lymphocytes, Helper-Inducer / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D006680:HLA Antigens; D007370:Interferon Type I; D007378:Interleukins